Warren Alpert Foundation Prize

Last updated June 22, 2023

The Warren Alpert Foundation Prize is awarded annually to scientist(s) whose scientific achievements have led to the prevention, cure or treatment of human diseases or disorders, and/or whose research constitutes a seminal scientific finding that holds great promise of ultimately changing our understanding of or ability to treat disease. The prize was established in 1987 by the late philanthropist and businessman Warren Alpert ^[1] and the Warren Alpert Foundation.

The prize is administered in concert with Harvard Medical School in Boston, Massachusetts and the Warren Alpert Foundation, located in Providence, Rhode Island. An annual symposium is held at Harvard Medical School each fall where the recipient(s) present their work. The prize currently includes $500,000,^[3] a citation and plaque.

Warren Alpert Foundation Prize Recipients

Year	Recipient(s)	Citation	Nationality
2023	David J. Lipman	For his visionary work in the conception, design, and implementation of computational tools, databases, and infrastructure that transformed the way biological information is analyzed and accessed freely and rapidly around the world.	United States
2022	Katalin Karikó, Drew Weissman, Eric Huang, Uğur Şahin, Özlem Türeci	For transformational discoveries into the biology of mRNA, for its modification for medicinal use, and for the design of mRNA-based COVID-19 vaccines.	United States Germany
2021	Lynne Maquat, Joan Steitz	For the discovery of fundamental pathways and mechanisms that ensure accurate RNA splicing and quality control of gene expression involving RNA.^[4]	United States
2020	Daniel Drucker, Joel Habener, Jens Juul Holst	For identifying Glucagon-like peptides and leading the field with studies extending from cells to humans, culminating in the development of these peptides as therapeutic agents for treating diabetes and short bowel syndrome.^[4]	Canada United States Denmark
2019	Ed Boyden, Karl Deisseroth, Peter Hegemann, Gero Miesenböck	For pioneering work in the field of optogenetics, a revolutionary technique that uses light and genetic modification to control the activity of cells in the brain.	United States Germany Austria
2018	Francis Collins, Paul Negulescu, Bonnie Ramsey, Lap-Chee Tsui, Michael J. Welsh	For identifying faulty gene behind devastating disease, development of precision-targeted therapies	United States China
2017	Arlene Sharpe, Harvard Medical School, Gordon Freeman, Dana Farber Cancer Institute, Lieping Chen, Yale University, James P. Allison, University of Texas M.D. Anderson Cancer Center, Tasuku Honjo, Kyoto University	For their collective contributions to the pre-clinical foundation and development of immune checkpoint blockade, a novel form of cancer therapy that has transformed the landscape of cancer treatment.^[3]	United States Japan
2016	Rodolphe Barrangou, North Carolina State University, Philippe Horvath, DuPont, Jennifer Doudna, University of California, Berkeley, Emmanuelle Charpentier, Max Planck Institute for Infection Biology and Umeå University, Virginijus Šikšnys, Vilnius University Institute of Biotechnology	For their remarkable contributions to the understanding of the CRISPR bacterial defense system and the revolutionary discovery that it can be adapted for genome editing ^[5]	France United States Lithuania
2015	Ruth Sonntag Nussenzweig and Victor Nussenzweig, NYU Langone Medical Center, Tu Youyou of the China Academy of Chinese Medical Sciences, Beijing	For their pioneering discoveries in chemistry and parasitology, and their personal commitment to translating these discoveries into effective chemotherapeutic and vaccine-based approaches to controlling malaria^[6]	Brazil China
2014	Dr. Oleh Hornykiewicz, Medical University of Vienna, Roger A. Nicoll, University of California, San Francisco, Dr. Solomon H. Snyder, Johns Hopkins School of Medicine	For seminal contributions to our understanding of neurotransmission and neurodegeneration.^[7]^[8]	Austria United States
2013	Dr. David Botstein, Princeton University, Ronald W. Davis, Stanford University School of Medicine, and Dr. David Hogness, Stanford University School of Medicine	For their seminal contributions to the concepts and methods of creating a genetic map in the human, and of positional cloning, leading to the identification of thousands of human disease genes and ushering in the era of human genetics.^[7]^[9]	United States
2012	Dr. Julian Adams, Infinity Pharmaceuticals, Dr. Kenneth C. Anderson, Dana–Farber Cancer Institute, Dr. Alfred L. Goldberg, Harvard Medical School, and Dr. Paul G. Richardson, Dana–Farber Cancer Institute^[10]	For the discovery, preclinical and clinical development of bortezomib to FDA approval and front line therapy for the treatment of patients with multiple myeloma.^[7]	United States
2011	Dr. Alain Carpentier, Hôpital Européen Georges-Pompidou, and Dr. Robert Langer, Massachusetts Institute of Technology	For their application of bioengineering principles to fundamental improvements in human health.^[7]^[11]	United States France
2009-2010	Dr. Howard Green, Harvard Medical School	For development of methodologies for the expansion and differentiation of human keratinocyte stem cells for permanent skin restoration in victims of extensive burns.^[7]^[12]	United States
2008	Dr. Lloyd Aiello, Joslin Diabetes Center	For the discovery, characterization and implementation of laser panretinal photocoagulation, which is used to treat proliferative diabetic retinopathy^[7]	United States
2007	Harald zur Hausen and Lutz Gissmann, German Cancer Research Center	For work leading to the development of a vaccine against human papillomavirus.^[13]	Germany
2006	Dennis Slamon, UCLA; Robert Weinberg, MIT; Michael Shepard, Receptor BioLogix, Inc; and Axel Ullrich, Center for Molecular Medicine,	For their work in identifying HER-2/neu as an oncogene and development of the anti-HER-2/neu monoclonal antibody Herceptin for breast cancer therapy.^[14]	United States Germany
2005	M. Judah Folkman, Harvard Medical School and Boston Children's Hospital	For discovering tumor angiogenesis, and for pioneering work in the development of antiangiogenic therapies for cancer.^[7]	United States
2004	Susan Band Horwitz, Albert Einstein College of Medicine	For her seminal contributions to the understanding of how the antitumor agent Taxol kills cancer cells.	United States
2003	Sidney Pestka, University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, David Goeddel, Tularik, Inc., and Charles Weissmann, Imperial College School of Medicine, London	For purification and characterization of interferon alpha; cloning of the human interferon alpha gene and mass production of recombinant interferon alpha for cancer treatment and treatment of hepatitis C.^[7]	United Kingdom United States
2002	Alfred Sommer, Johns Hopkins University Bloomberg School of Public Health	For epidemiologic insight into the effects of Vitamin A deficiency, and the resulting reduction in childhood mortality worldwide.^[7]	United States
2001	Eugene Braunwald, Harvard Medical School, and Barry Coller, Rockefeller University School of Medicine.	For work in cardiac physiology and pathophysiology, leading to the use of monoclonal antibodies to platelet surface antigens in antithrombotic therapy.^[7]	United States
2000	David Baltimore, California Institute of Technology, Brian Druker, Oregon Health Sciences University, Nicholas Lydon, Amgen, Inc., Alex Matter, Novartis Pharma AG, and Owen Witte, University of California, Los Angeles.	For Development of Abl kinase inhibitors for use in the treatment of chronic myelogenous leukemia ^[7]	United States Switzerland
1999	Michael S. Brown and Joseph L. Goldstein, University of Texas Southwestern Medical School, Akira Endo (biochemist), Tokyo Noko University	For Development of HMG CoA reductase inhibitors.^[7]	United States Japan
1998	K. Frank Austen, Harvard Medical School	For elucidating the role of leukotrienes in asthma.^[7]	United States
1997	Robert C. Gallo, University of Maryland School of Medicine, and Luc Montagnier, Queens College, New York	For isolation of the Human Immunodeficiency Virus.^[7]	United States France
1996	Leo Sachs, Weizmann Institute of Science, and Donald Metcalf, University of Melbourne	For discovery of blood cell growth factors.^[7]	Israel Australia
1995	John A. Clements, University of California, San Francisco	For discovery of lung surfactant, and development of synthetic lung surfactant therapy for Infant Respiratory Distress Syndrome.^[7]	United States
1994	J.R. Warren, Royal Perth Hospital, and Barry J. Marshall, University of Virginia	For linking gastric ulcers to the H. pylori bacterium.^[7]	Australia
1993	Stuart H. Orkin, Harvard Medical School.	For genetic and molecular mechanisms of Βeta-Thalassemia and other blood disorders.^[7]	United States
1992	Roscoe O. Brady, National Institutes of Health	For treatment for Gaucher's Disease.^[7]	United States
1991	David W. Cushman and Miguel A. Ondetti, Bristol Myers-Squibb	For ACE inhibitor therapy for hypertension and heart failure.^[7]	United States Argentina
1990	No prize awarded.^[7]
1989	Yuet Wai Kan, University of California, San Francisco	For prenatal genetic screening for blood diseases.^[7]	United States
1988	Louis Kunkel, Harvard Medical School	For discovery of the gene associated with a major form of muscular dystrophy.^[7]	United States
1987	Kenneth Murray (biologist), University of Edinburgh	For development of a vaccine against Hepatitis B.^[7]	Scotland

Related Research Articles

The Warren Alpert Medical School is the medical school of Brown University, located in Providence, Rhode Island. Originally established in 1811, it was the third medical school to be founded in New England after only Harvard and Dartmouth. However, the original program was suspended in 1827, and the four-year medical program was re-established almost 150 years later in 1972, granting the first MD degrees in 1975.

Massachusetts General Hospital is the original and largest teaching hospital of Harvard Medical School located in the West End neighborhood of Boston, Massachusetts, United States. It is the third-oldest general hospital in the United States and has a capacity of 999 beds. With Brigham and Women's Hospital, it is one of the two founding members of Mass General Brigham, the largest healthcare provider in Massachusetts. Massachusetts General Hospital houses the largest hospital-based research program in the world, the Mass General Research Institute, with an annual research budget of more than $1 billion in 2019. It is currently ranked as the eighth-best hospital in the United States by U.S. News & World Report.

<span class="mw-page-title-main">Janet Rowley</span> American human geneticist

Janet Davison Rowley was an American human geneticist and the first scientist to identify a chromosomal translocation as the cause of leukemia and other cancers, thus proving that cancer is a genetic disease. Rowley spent the majority of her life working in Chicago and received many awards and honors throughout her life, recognizing her achievements and contributions in the area of genetics.

Robert Samuel Langer Jr. FREng is an American chemical engineer, scientist, entrepreneur, inventor and one of the nine Institute Professors at the Massachusetts Institute of Technology.

Dana–Farber Cancer Institute is a comprehensive cancer treatment and research institution in Boston, Massachusetts. Dana–Farber is the founding member of Dana–Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.

Gero Andreas Miesenböck is an Austrian scientist. He is currently Waynflete Professor of Physiology and Director of the Centre for Neural Circuits and Behaviour (CNCB) at the University of Oxford and a fellow of Magdalen College, Oxford.

The Dr. Paul Janssen Award for Biomedical Research is given annually by Johnson & Johnson to honor the work of an active scientist in academia, industry or a scientific institute in the field of biomedical research. It was established in 2004 and perpetuates the memory of Paul Janssen, the founder of Janssen Pharmaceutica, a Johnson & Johnson subsidiary.

<span class="mw-page-title-main">Edward Boyden</span> American neuroscientist

Edward S. Boyden is an American neuroscientist at MIT. He is the Y. Eva Tan Professor in Neurotechnology, a faculty member in the MIT Media Lab and an associate member of the McGovern Institute for Brain Research. In 2018 he was named a Howard Hughes Medical Institute Investigator. He is recognized for his work on optogenetics. In this technology, a light-sensitive ion channel such as channelrhodopsin-2 is genetically expressed in neurons, allowing neuronal activity to be controlled by light. There were early efforts to achieve targeted optical control dating back to 2002 that did not involve a directly light-activated ion channel, but it was the method based on directly light-activated channels from microbes, such as channelrhodopsin, emerging in 2005 that turned out to be broadly useful. Optogenetics in this way has been widely adopted by neuroscientists as a research tool, and it is also thought to have potential therapeutic applications. Boyden joined the MIT faculty in 2007, and continues to develop new optogenetic tools as well as other technologies for the manipulation of brain activity. Previously, Boyden received degrees in electrical engineering, computer science, and physics from MIT. During high school, Boyden attended the Texas Academy of Mathematics and Science.

Sidney Pestka was an American biochemist and geneticist. A recipient of the National Medal of Technology, he is sometimes referred to as the "father of interferon" for his groundbreaking work developing the interferons as treatments for major diseases such as hepatitis, multiple sclerosis, and cancer. Pestka was part of the team working on research involving the genetic code, protein synthesis and ribosome function that led to the 1968 Nobel Prize in Physiology or Medicine received by Marshall Warren Nirenberg.

George Quentin Daley is the Dean of the Faculty of Medicine, Caroline Shields Walker Professor of Medicine, and Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. He was formerly the Robert A. Stranahan Professor of Pediatrics at Harvard Medical School, Director of the Stem Cell Transplantation Program at Boston Children's Hospital, and an investigator of the Howard Hughes Medical Institute, Associate Director of Children's Stem Cell Program, a member of the Executive Committee of the Harvard Stem Cell Institute. He is a past president of the International Society for Stem Cell Research (2007–2008).

Laurie Hollis Glimcher is an American physician-scientist who was appointed president and CEO of Dana–Farber Cancer Institute in October 2016. She was elected a Member of the American Philosophical Society in 2019.

Lynne Elizabeth Maquat is an American biochemist and molecular biologist whose research focuses on the cellular mechanisms of human disease. She is an elected member of the American Academy of Arts and Sciences, the National Academy of Sciences and the National Academy of Medicine. She currently holds the J. Lowell Orbison Endowed Chair and is a professor of biochemistry and biophysics, pediatrics and of oncology at the University of Rochester Medical Center. Professor Maquat is also Founding Director of the Center for RNA Biology and Founding Chair of Graduate Women in Science at the University of Rochester.

Stuart Holland Orkin is an American physician, stem cell biologist and researcher in pediatric hematology-oncology. He is the David G. Nathan Distinguished Professor of Pediatrics at Harvard Medical School. Orkin's research has focused on the genetic basis of blood disorders. He is a member of the National Academy of Sciences and the Institute of Medicine, and an Investigator of the Howard Hughes Medical Institute.

William G. Kaelin Jr. is an American Nobel laureate physician-scientist. He is a professor of medicine at Harvard University and the Dana–Farber Cancer Institute. His laboratory studies tumor suppressor proteins. In 2016, Kaelin received the Albert Lasker Award for Basic Medical Research and the AACR Princess Takamatsu Award. He also won the Nobel Prize in Physiology or Medicine in 2019 along with Peter J. Ratcliffe and Gregg L. Semenza.

Arlene Helen Sharpe is an American immunologist and Kolokotrones University Professor at Harvard University and Chair of the Department of Immunology at Harvard Medical School. In 2017, she received the Warren Alpert Foundation Prize with Gordon Freeman, Lieping Chen, James P. Allison and Tasuku Honjo for their collective contributions to the pre-clinical foundation and development of immune checkpoint blockade, a novel form of cancer therapy that has transformed the landscape of cancer treatment. She served as the hundredth president of the American Association of Immunologists from 2016 to 2017 and served as an AAI Council member from 2013 to 2016. She is the co-director of the Evergrande Center for Immunologic Diseases at Harvard Medical School and Brigham and Women's Hospital.

Bonnie W. Ramsey is the Endowed Chair in Cystic Fibrosis at the University of Washington School of Medicine and the director of the Center for Clinical and Translational Research at Seattle Children's Research Institute. Her research focuses on treatments for cystic fibrosis.

<span class="mw-page-title-main">Warren Alpert</span> American entrepreneur and philanthropist

Warren Alpert was an American entrepreneur and philanthropist. Born to poor immigrant parents, he served in U.S. military intelligence during World War II. His privately held businesses distributed gasoline, tobacco and food, and operated a chain of convenience stores and gas stations in the Northeastern United States. He gave away much of his fortune to support medical research at universities and hospitals, donating hundreds of millions of dollars.

Matthew Langer Meyerson is an American pathologist and the Charles A. Dana Chair in Human Cancer Genetics at the Dana-Farber Cancer Institute. He is also director of the Center for Cancer Genomics at the Dana-Farber Cancer Institute, and the Director of Cancer Genomics at the Broad Institute of MIT and Harvard.

Barry Spencer Coller is an American physician known for his research in platelet physiology and for inventing the Abciximab. He is the David Rockefeller Professor, Physician-In-Chief, and Vice President for Medical Affairs at Rockefeller University.

Sun Hur is a South Korean-born scientist. She is an Oscar M. Schloss Professor at Harvard Medical School and Boston Children's Hospital and an investigator in the Howard Hughes Medical Institute.

References

↑ Hevesi, Dennis (2007-03-10). "Warren Alpert, 86, Entrepreneur, Is Dead". The New York Times. ISSN 0362-4331 . Retrieved 2019-07-16.
↑ "2019 Warren Alpert Prize Recipients Announced | Warren Alpert Foundation Prize". warrenalpert.org. Retrieved 2019-07-16.
1 2 "Prize | Warren Alpert Foundation Prize". warrenalpert.org. Retrieved 2019-07-16.
1 2 Prize Recipients | Warren Alpert Foundation Prize
↑ "Alpert Prize Recognizes CRISPR Pioneers". Warren Alpert Foundation. Retrieved 10 March 2016.
↑ "2015 Waren Alpert Foundation Prize recognizes Malaria Breakthroughs". Warren Alpert Foundation. Retrieved 16 August 2015.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 "Warren Alpert Foundation Prize announcement" . Retrieved 5 July 2013.
↑ Office of Communications and External Relations, Harvard Medical School. "Warren Alpert Foundation Prize Recognizes Leaders in Brain Research" . Retrieved 10 June 2014.
↑ Office of Communications and External Relations, Harvard Medical School. "Alpert Foundation Recognizes Genetic Pioneers" . Retrieved 5 July 2013.
↑ Conaboy, Chelsea (13 June 2012). "$250,000 Warren Alpert prize goes to researchers for work on blood cancer drug". Boston Globe. Retrieved 13 July 2012.
↑ Office, MIT News. "Langer wins 2011 Warren Alpert Prize" . Retrieved 13 July 2012.
↑ Schorr, Melissa (22 April 2012). "Harvard biologist Dr. Howard Green's $250,000 prize". Boston Globe. Retrieved 13 July 2012.
↑ Medical School, Harvard. "HPV, cervical cancer link earns scientists Alpert Prize" . Retrieved 13 July 2012.
↑ Medical School, Harvard. "Alpert Winners Trace Path to Life-saving Drug" . Retrieved 13 July 2012.

External links

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.

[1] Hevesi, Dennis (2007-03-10). "Warren Alpert, 86, Entrepreneur, Is Dead". The New York Times. ISSN 0362-4331 . Retrieved 2019-07-16.

[2] "2019 Warren Alpert Prize Recipients Announced | Warren Alpert Foundation Prize". warrenalpert.org. Retrieved 2019-07-16.

[warren-3] 1 2 "Prize | Warren Alpert Foundation Prize". warrenalpert.org. Retrieved 2019-07-16.

[autogenerated1-4] 1 2 Prize Recipients | Warren Alpert Foundation Prize

[5] "Alpert Prize Recognizes CRISPR Pioneers". Warren Alpert Foundation. Retrieved 10 March 2016.

[6] "2015 Waren Alpert Foundation Prize recognizes Malaria Breakthroughs". Warren Alpert Foundation. Retrieved 16 August 2015.

[Warren_Alpert_Prize_Foundation_website-7] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 "Warren Alpert Foundation Prize announcement" . Retrieved 5 July 2013.

[8] Office of Communications and External Relations, Harvard Medical School. "Warren Alpert Foundation Prize Recognizes Leaders in Brain Research" . Retrieved 10 June 2014.

[9] Office of Communications and External Relations, Harvard Medical School. "Alpert Foundation Recognizes Genetic Pioneers" . Retrieved 5 July 2013.

[$250,000_Warren_Alpert_prize_goes_to_researchers_for_work_on_blood_cancer_drug-10] Conaboy, Chelsea (13 June 2012). "$250,000 Warren Alpert prize goes to researchers for work on blood cancer drug". Boston Globe. Retrieved 13 July 2012.

[11] Office, MIT News. "Langer wins 2011 Warren Alpert Prize" . Retrieved 13 July 2012.

[12] Schorr, Melissa (22 April 2012). "Harvard biologist Dr. Howard Green's $250,000 prize". Boston Globe. Retrieved 13 July 2012.

[13] Medical School, Harvard. "HPV, cervical cancer link earns scientists Alpert Prize" . Retrieved 13 July 2012.

[14] Medical School, Harvard. "Alpert Winners Trace Path to Life-saving Drug" . Retrieved 13 July 2012.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

[14]

Warren Alpert Foundation Prize

Contents